Table-1:
Isoforms | Alterations | Cell line/Model/Organism | Mode of mechanism | Ref |
---|---|---|---|---|
Hif1α | Overexpression | peri-infarct of sheep (n=6) undergoing coronary occlusion | Reduced infarct size and improved LV systolic performance increased neovascularization | Chen et al., 2022 |
Hif1α null mouse model | Increased HIF2Α Increased mitochondrial number Impaired embryonic glycolysis Activation of amino acid catabolism |
Eubank et al., 2011 | ||
Knockdown | H9c2 cells exposed to high glucose | Downregulated angiopoietin-like protein 2, alleviating the hypoxia injury by promoting nrf2 and HO-1 expression | Ghosh et al., 2021 | |
Hif2α | Overexpression | 46C ESC cell line | Promotes cardiomyogenesis by wnt/β-catenin pathway | Hickey et al., 2010 |
Knockdown | VHLR200W (Chuvash Polycythemia)mouse model | Normalized erythropoietin and endothelin level suppressed both the polycythemia and pulmonary hypertension partial protection against vascular remodeling, haemorrhage, and edema |
Hnatiuk et al., 2016
Menendez-Montes et al., 2021 |
|
HIF-1αflox/flox/LysMcre knockout mice | Inhibited soluble form of the VEGF receptor-1 (sVEGFR-1) production in a hypoxic condition Production of VEGF was unaffected |
Sun et al., 2015 | ||
Hif3α | Overexpression | - | - | |
Knockdown | Hep3B hepatoma cells | Downregulation of EPO gene | Tolonen et al., 2020 | |
Hif3α2 | Overexpression | Hep3B hepatoma cells SK-N-AS cells | Promotes expression of erythropoietin gene (EPO), BMP6, PTX3 | Tolonen et al., 2020 |
Knockdown | - | - | - |